Emily P. English, PhD, is the CEO of Gemstone Biotherapeutics. In her current role, she is guiding the commercialization of Gemstone’s innovative biomaterials technology, with a goal of bringing solutions for scar-free skin regeneration to market. She has published seven peer-reviewed papers, holds four patents, and is the principal investigator on three active grants. Prior to joining Gemstone, Dr. English spent eight years at the JHUAPL, where she led a team of 35 scientists and engineers. She holds a Bachelor’s degree from UMCP and a Ph.D. in chemistry from the University of Wisconsin, Madison.